SAN ANTONIO — Detection of circulating tumor DNA after neoadjuvant chemotherapy appeared to independently predict disease recurrence among women with early-stage triple-negative breast cancer, according to preplanned analyses of results from the randomized phase 2 BRE12-158 trial presented at San Antonio Breast Cancer Symposium.“We are obviously very excited by these findings,”
Editor’s note: This is a developing news story. Please check back soon for updates. Bausch + Lomb will return its enVista IOLs to market after…
A trial of the influenza antiviral baloxavir suggests that the drug could be used as post-exposure prophylaxis to prevent infection among household contacts of someone…
In this episode, host Shikha Jain, MD, speaks with Nadine Spring, PhD, about the importance of DEI in clinical care, driving positive social change forward…
Teenagers and young adults vaping daily/near daily with a desire to quit had better abstinence when treated with 12-week varenicline vs. placebo, according to results…
Health savings accounts are a powerful tool for managing health care expenses, offering significant tax advantages and flexibility.
Updated recommendations from an international group of diabetes experts aim to inform diabetes educators about best practices for insulin injections. The Forum for Injection Technique…
HHS Secretary Robert F. Kennedy Jr. declared that the new administration will identify an environmental toxin causing autism in a matter of months, but experts…
Health savings accounts are a powerful tool for managing health care expenses, offering significant tax advantages and flexibility.
SAN DIEGO — Speakers at an American Academy of Orthopaedic Surgeons Annual Meeting town hall said with the use of AI on the rise in…
Health savings accounts are a powerful tool for managing health care expenses, offering significant tax advantages and flexibility.
